Clinical Trials · NCT04097600
A Research Study Comparing Active Drug in the Blood in Healthy Participants Following Dosing of the Current and a New Formulation (D) Semaglutide Tablets
- Phase
- Phase 1
- Recruitment status
- Completed
- Sponsor
- Novo Nordisk A/S
- Enrollment
- 274
- Start date
- Sep 2019
- Locations
- 1 site, Germany
- Primary endpoint
- AUC0-24h,sema,SS; area under the semaglutide plasma concentration-time curve during a dosing interval at steady state